Diabetic neuropathy involves nerve degeneration such that patients can experience pain or, more commonly, lose sensation in their legs and feet, making it very difficult to walk. Neuropathy is closely associated with vascular disease – inhibited peripheral blood circulation – which frequently causes ulceration -skin sores that don’t heal.
In a study conducted in 2002 we solicited 20 diabetic patients from doctors on our mailing list, and entered them into a pilot study based on both the existence of substantial symptoms and the completion of an examination and report from their doctor. With 17 out of 20 doctors responding, 76% of patients showed significant improvement after 8 weeks. The graph bellow shows in blue bars the reduction in severity on different symptoms after 2 months treatment. Click here for research study.
After six months 6 participants out of 20 had dropped out the study. In the remaining group of 14 participants, 9 participants had continued to use the Infratonic therapy protocol as outlined and 5 had departed from the protocol or stopped it entirely. It would be impractical to consider the results of those who chose to alter the protocol in the same statistical grouping as those who continued to rigorously adhere to the treatment plan, so we have presented their results separately. The results appearing below show that the progress made by these two distinctly separate groups is markedly different.
After 6 month treatment those participants that continued to use Infratonic therapy regularly, following the protocol, continued to improve in every category (the rise in Ulceration from the Pre-Treatment measurement to the Two-Month measurement was caused by one individual developing a secondary site); those participants who either discontinued use or altered the protocol during the study saw their condition continue to deteriorate, often beyond the Pre-Treatment measurement levels.
We have learned two valuable lessons at this point in the study. First, the continued use of Infratonic therapy provided steady progress for the participants. Diabetic neuropathy is a long term, degenerative disease whose symptoms normally continue to worsen, and a therapy method that slows the downward spiral is a remarkable accomplishment; but to see an improvement, even a slow and steady one, provides tremendous hope for the many who suffer daily. The second lesson is just as significant – this is a commitment to improvement in the quality of one’s life that requires a continuity of care. It is vitally important that the therapy continue regularly, as the potential for relief is dependent upon it.